Clinical & Commercial Oral Solid Dose CDMO – Asset Overview Opportunity
Oral Solid Dose (OSD) Tablets & Capsules facility, 45 minutes from Boston.
$20 mIllion in facility value / equipment. Hand full of active customers, $2-3 Million in annual sales, break even EBITDA
40,000 Sqft, 2,500 cGMP, DEA license, and FDA approved. Limited staff of around 10.
We are looking for $8 mIllion for the real estate & business.
Take a look at our prospective
Privately-owned OSD CDMO located on East Coast just 75
minutes away from central Boston.
+ FDA Registered and Inspected – 17 FDA Product Approvals.
+ DEA Licensed and Inspected – Schedule CII through CV for
controlled chemical substances manufactured under cGMP.
+ Clinical Trial Material (CTM) and Commercial Tablets &
Capsules suites across the site.
+ Formulation Development, Analytical Development, PI-III
CTM Scale-up and cGMP Manufacturing.
+ Immediate, Modified, and Extended Release OSD Products.
+ Extended Release Technology is Proprietary.
+ 40,000 ft² facility of which 12,000 ft² is cGMP with an
additional 60,000 ft² opportunity for expansion.
+ $10 Million CapEx investment in 2017.
+ $3 Million in 2021, with break even run rate. $40M in
annual revenue opportunity with no CapX investment.
+ Please request the CIM after Fully Executed NDA.